Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | UGT2B7 | P16662 | 1/20 | 0.35 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.35 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.35 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.33 |
| ▸ | AKT1 | P31749 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | NOX1 | Q9Y5S8 | 1/20 | 0.31 |
| ▸ | NOS3 | P29474 | 1/20 | 0.30 |
| ▸ | NOS1 | P29475 | 1/20 | 0.30 |
| ▸ | SLC5A1 | P13866 | 1/20 | 0.30 |
| ▸ | SLC5A2 | P31639 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Fumaric Acid SCHEMBL30462200 | 0.89 | ALDH1A1 (0.33) | — | |
| SCHEMBL27543040 | 0.86 | ADRB2 (0.32) | ADRB2TSHR | |
| SCHEMBL28745679 | 0.86 | ADRB2 (0.32) | ADRB2TSHR | |
| SCHEMBL9574118 | 0.85 | ALOX15 (0.32) | ALOX15ALOX12ADRB2 | |
| SCHEMBL2012341 | 0.82 | NFKB1 (0.41) | ALOX15ADRB2TSHR | |
| SCHEMBL2569901 | 0.82 | ADRB2 (0.38) | ADRB2 | |
| SCHEMBL7580541 | 0.82 | BLM (0.41) | ADRB2TSHR | |
| SCHEMBL17651818 | 0.82 | ADRB2 (0.38) | ADRB2TSHRSLC5A1SLC5A2 | |
| SCHEMBL828863 | 0.82 | ADRB2 (0.38) | ADRB2 | |
| SCHEMBL7582207 | 0.82 | BLM (0.41) | ADRB2TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116283512-B | Method for synthesizing vilanabro and salts thereof | 博诺康源(北京)药业科技有限公司 | 2025-04-25 | — | — | CN | claimed |
| CN-114539077-B | Synthesis method of levosalbutamol hydrochloride | 南京恒道医药科技股份有限公司 | 2023-12-08 | — | — | CN | claimed |
| CN-116283512-A | Method for synthesizing vilanabro and salts thereof | 博诺康源(北京)药业科技有限公司 | 2023-06-23 | — | — | CN | claimed |
| CN-114539077-A | Synthesis method of levalbuterol hydrochloride | 南京恒道医药科技有限公司 | 2022-05-27 | — | — | CN | claimed |
| CN-116283512-B | Method for synthesizing vilanabro and salts thereof | 博诺康源(北京)药业科技有限公司 | 2025-04-25 | — | — | CN | disclosed |
| CN-118715200-A | Process for preparing vilantrum Luo San phenylacetate | 好利安科技有限公司 | 2024-09-27 | — | — | CN | disclosed |
| CN-114539077-B | Synthesis method of levosalbutamol hydrochloride | 南京恒道医药科技股份有限公司 | 2023-12-08 | — | — | CN | disclosed |
| CN-114539077-B | Synthesis method of levosalbutamol hydrochloride | 南京恒道医药科技股份有限公司 | 2023-12-08 | — | — | CN | disclosed |
| CN-116283512-A | Method for synthesizing vilanabro and salts thereof | 博诺康源(北京)药业科技有限公司 | 2023-06-23 | — | — | CN | disclosed |
| CN-114539077-A | Synthesis method of levalbuterol hydrochloride | 南京恒道医药科技有限公司 | 2022-05-27 | — | — | CN | disclosed |
| CN-114539077-A | Synthesis method of levalbuterol hydrochloride | 南京恒道医药科技有限公司 | 2022-05-27 | — | — | CN | disclosed |
| CN-103288793-A | Phenethanolamine derivatives for treatment of respiratory diseases | GLAXO GROUP LTD | 2013-09-11 | — | — | CN | disclosed |
| CN-101701006-A | Phenethanolamine derivatives for treatment of respiratory diseases | GLAXO GROUP LTD | 2010-05-05 | — | — | CN | disclosed |
| EP-1885684-A1 | DERIVATIVES OF 4-(2-AMINO-1-HYDROXYETHYL)PHENOL AS AGONISTS OF THE BETA-2 ADRENERGIC RECEPTOR | Laboratorios Almirall, S.A. (ES) | 2008-02-13 | — | — | EP | disclosed |
| WO-2006122788-A1 | DERIVATIVES OF 4-(2-AMINO-1-HYDROXYETHYL)PHENOL AS AGONISTS OF THE β2 ADRENERGIC RECEPTOR | LABORATORIOS ALMIRALL, S.A. (ES) | 2006-11-23 | — | — | WO | disclosed |
| CN-1732152-A | Phenylethanolamine derivatives for the treatment of respiratory diseases | GLAXO GROUP LTD (GB) | 2006-02-08 | — | — | CN | disclosed |
| EP-1554264-A2 | MEDICINAL ARYLETHANOLAMINE COMPOUNDS | GLAXO GROUP LIMITED (GB) | 2005-07-20 | — | — | EP | disclosed |
| CN-1585633-A | Phenylethanolamine derivatives for the treatment of respiratory diseases | GLAXO GROUP LTD (GB) | 2005-02-23 | — | — | CN | disclosed |
| WO-2004037807-A9 | MEDICINAL ARYLETHANOLAMINE COMPOUNDS | GLAXO GROUP LTD (GB) | 2004-08-19 | — | — | WO | disclosed |
| WO-2004037807-A2 | MEDICINAL ARYLETHANOLAMINE COMPOUNDS | GLAXO GROUP LIMITED (GB) | 2004-05-06 | — | — | WO | disclosed |